DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Solms A, Iorio A, Ahsman MJ. et al.
Favorable pharmacokinetic characteristics of extended-half-life recombinant factor VIII BAY 94-9027 enable robust individual profiling using a population pharmacokinetic approach.
Clin Pharmacokinet 2020;
59 (05) 605-616
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.